{"id":1498,"date":"2021-07-29T09:57:13","date_gmt":"2021-07-29T06:57:13","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=1498"},"modified":"2021-07-29T09:57:13","modified_gmt":"2021-07-29T06:57:13","slug":"gen-ilac","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=1498","title":{"rendered":"GEN, K\u00fcresel Bir Oyuncu Olma Yolunda!"},"content":{"rendered":"

Gen \u0130la<\/strong>\u00e7<\/strong> ve Sa\u011fl\u0131k \u00dcr\u00fcnleri Sanayi ve Ticaret A.\u015e.\u2019nin (GEN) halka arz\u0131 onayland\u0131. GEN\u2019in halka arz\u0131 GENIL kodu ile 28-29-30 Temmuz tarihleri aras\u0131nda ger\u00e7ekle\u015ftirilecek. Halka arz s\u00fcreci ile yat\u0131r\u0131mlar\u0131n\u0131 art\u0131rmak ve sekt\u00f6rdeki yerini daha da g\u00fc\u00e7lendirmek istediklerini belirten GEN Y\u00f6netim Kurulu Ba\u015fkan\u0131 Abidin G\u00fclm\u00fc\u015f, bas\u0131n mensuplar\u0131 ile bir araya geldi. G\u00fclm\u00fc\u015f, \u00e7evrimi\u00e7i ger\u00e7ekle\u015ftirilen toplant\u0131da, \u015firketin sekt\u00f6rdeki yeri hakk\u0131nda bilgiler verdi ve gazetecilerin sorular\u0131n\u0131 yan\u0131tlad\u0131.<\/strong><\/p>\n

\"\"GEN\u2019in paylar\u0131n\u0131n halka arz\u0131 i\u00e7in yapt\u0131\u011f\u0131 izahname ba\u015fvurusunun Sermaye Piyasas\u0131 Kurulu (SPK) taraf\u0131ndan onaylanmas\u0131 ile s\u00fcrecin ba\u015flad\u0131\u011f\u0131n\u0131 aktaran G\u00fclm\u00fc\u015f, \u015firket olarak \u00e7ok heyecanl\u0131 olduklar\u0131n\u0131 ve beklentilerinin y\u00fcksek oldu\u011funu belirterek konu\u015fmas\u0131na ba\u015flad\u0131.<\/p>\n

\u201cNadir hastal\u0131klarda akla gelen ilk firmay\u0131z\u201d<\/strong><\/p>\n

GEN olarak, nadir hastal\u0131\u011fa sahip ki\u015filere yeni tedavi se\u00e7enekleri sunmaya \u00e7al\u0131\u015ft\u0131klar\u0131n\u0131 belirten Abidin G\u00fclm\u00fc\u015f, 1999 y\u0131l\u0131nda ilk ila\u00e7 ruhsat\u0131n\u0131 almalar\u0131yla beraber kendilerine cesur ve yenilik\u00e7i bir yol haritas\u0131 \u00e7izdiklerini aktard\u0131. \u201cBug\u00fcn geldi\u011fimiz noktada e\u011fer uluslararas\u0131 bir biyoteknoloji firmas\u0131 T\u00fcrkiye pazar\u0131na girmek istiyorsa mutlaka yolu GEN\u2019den ge\u00e7iyor. Nadir hastal\u0131klar\u0131n tedavisi denilince akla ilk gelen firma olman\u0131n hakl\u0131 gururunu ya\u015f\u0131yoruz\u201d \u015feklinde konu\u015fan G\u00fclm\u00fc\u015f, \u015fu an itibariyle 20 partnerle, T\u00fcrkiye, Rusya, Azerbaycan, Kazakistan ve \u00d6zbekistan gibi bir\u00e7ok \u00fclkede \u00e7al\u0131\u015fmalar\u0131na ve yat\u0131r\u0131mlar\u0131na devam ettiklerini belirtti.<\/p>\n

\u201cGelirin b\u00fcy\u00fck bir k\u0131sm\u0131 k\u00fcresel oyuncu olmak i\u00e7in kullan\u0131lacak\u201d<\/strong><\/p>\n

\"\"G\u00fclm\u00fc\u015f, 23 y\u0131l\u0131 kapsayan deneyimleri, yat\u0131r\u0131mlar\u0131, Ar-Ge \u00e7al\u0131\u015fmalar\u0131 ve uluslararas\u0131 ortakl\u0131klar\u0131 ile ila\u00e7 sekt\u00f6r\u00fcnde sa\u011flam ad\u0131mlar att\u0131klar\u0131n\u0131 belirterek bu ad\u0131mlar\u0131 h\u0131zland\u0131rmay\u0131 hedeflediklerini aktard\u0131. \u201cEn b\u00fcy\u00fck hedefimiz, 3 y\u0131ll\u0131k s\u00fcre\u00e7 i\u00e7erisinde \u00fcretti\u011fimiz \u00fcr\u00fcnlerin y\u00fczde 70\u2019ini ihra\u00e7 edebilir bir konuma gelmek\u201d \u015feklinde konu\u015fan G\u00fclm\u00fc\u015f, halka arzdan elde edilen gelirin b\u00fcy\u00fck bir k\u0131sm\u0131n\u0131 k\u00fcresel bir oyuncu olmak i\u00e7in harcayacaklar\u0131n\u0131 aktard\u0131.<\/p>\n

\u201cT\u00fcrkiye\u2019de \u00fcretilen bir \u00fcr\u00fcn\u00fc d\u00fcnyan\u0131n kullan\u0131m\u0131na sunmak istiyoruz\u201d<\/strong><\/p>\n

FDA (Amerikan \u0130la\u00e7 ve G\u0131da Dairesi) ve EMA\u2019dan (Avrupa \u0130la\u00e7 Ajans\u0131) onay beklediklerini de s\u00f6zlerine ekleyen G\u00fclm\u00fc\u015f, \u201cT\u00fcrkiye\u2019de hen\u00fcz yap\u0131lmayan\u0131 yapmak, \u00f6n klinik \u00e7al\u0131\u015fmalardan ba\u015flayarak faz 1-2-3 \u00e7al\u0131\u015fmalar\u0131n\u0131n T\u00fcrkiye\u2019de yap\u0131ld\u0131\u011f\u0131 bir \u00fcr\u00fcn\u00fc t\u00fcm d\u00fcnyan\u0131n kullan\u0131m\u0131na sundu\u011fumuzu g\u00f6stermek istiyoruz. \u015eimdiye kadarki birikimlerimiz, uzman kadromuz ve halka arz ile geni\u015fleyecek olan yat\u0131r\u0131mlar\u0131m\u0131z sayesinde bunu yapabilece\u011fimizi biliyoruz. Bizim tek hedefimiz b\u00fcy\u00fcmek\u201d \u015feklinde konu\u015ftu.<\/p>\n","protected":false},"excerpt":{"rendered":"

Gen \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri Sanayi ve Ticaret A.\u015e.\u2019nin (GEN) halka arz\u0131 onayland\u0131. GEN\u2019in halka arz\u0131 GENIL kodu ile 28-29-30 Temmuz tarihleri aras\u0131nda ger\u00e7ekle\u015ftirilecek. Halka arz s\u00fcreci ile yat\u0131r\u0131mlar\u0131n\u0131 art\u0131rmak ve sekt\u00f6rdeki yerini daha da g\u00fc\u00e7lendirmek istediklerini belirten GEN Y\u00f6netim Kurulu Ba\u015fkan\u0131 Abidin G\u00fclm\u00fc\u015f, bas\u0131n mensuplar\u0131 ile bir araya geldi. G\u00fclm\u00fc\u015f, \u00e7evrimi\u00e7i ger\u00e7ekle\u015ftirilen toplant\u0131da, \u015firketin …<\/p>\n","protected":false},"author":1,"featured_media":1499,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,3],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/1498"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1498"}],"version-history":[{"count":2,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/1498\/revisions"}],"predecessor-version":[{"id":1502,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/1498\/revisions\/1502"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/1499"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}